First FDA-Approved Therapy for Repigmentation Is a Breakthrough for Vitiligo, Says Dr Brett King
November 11th 2022Prior to this first therapy for repigmentation being approved, the only approved therapy was a depigmenting agent, which is usually the opposite of what providers are trying to accomplish with treatment.
Read More
The Department of Veterans Affairs (VA) will give cancer claims priority when a new law takes effect in January 2023; Pfizer is looking to use its COVID-19 profits to grow other blockbusters; the probable loss of Medicaid coverage for millions next year is setting off debate.
Read More
Dr Soyini Hawkins: Treating Endometriosis Requires Goals for the Rest of a Patient’s Life
November 4th 2022Since endometriosis is a chronic disease, treating it cannot be approached with a “one-and-done” mentality, said Soyini Hawkins, MD, gynecologist at Fibroid and Pelvic Wellness Center of Georgia.
Read More
Pfizer’s updated COVID-19 booster was found to be nearly 4 times more efficacious against Omicron in older adults; CDC released more flexible guidelines for clinicians prescribing opioids; Senator Mark Warner released a report offering solutions to cybersecurity threats to the health care sector.
Read More
The HHS renewed the national public health emergency for the monkeypox outbreak in the United States; more demand for amoxicillin has led to a nationwide shortage as respiratory illnesses continue to spread; a drug already approved for weight loss in adults has demonstrated promise in teenagers aged 12 to 17 years.
Read More
FDA advisers met to discuss alternatives to the infrared light used in pulse oximeters, which can be absorbed by melanin; FDA warns of a national shortage of tracheostomy tubes, especially for pediatric patients; 1 in 5 deaths among adults aged between 20 and 49 years is due to excessive drinking.
Read More
Pfizer’s maternal respiratory syncytial virus (RSV) vaccine was found to be highly effective in infants' first 6 months of life; survey shows long COVID-19 is more common among women than men; some voters worry that a Republican-controlled Congress could put science and science policy on the line.
Read More
Dr Peter A. Lio: “Explosion of New Treatments” for Atopic Dermatitis
October 31st 2022Atopic dermatitis is a common disease that has seen an explosion of new treatments in the last decade, explained Peter A. Lio, MD, clinical assistant professor of pediatrics and dermatology, Northwestern Feinberg School of Medicine.
Read More
What We’re Reading: Abortion Rate Drops; Rebound of COVID-19 Symptoms; Marketplace Enrollment Opens
October 31st 2022The legal abortion rate has fallen 6% since the overturning of Roe v Wade; 30% of patients with COVID-19 experienced a rebound in symptoms after 2 consecutive days without; open enrollment for Affordable Care Act marketplace insurance begins this week.
Read More
CVS Health and a digital diagnostic startup will produce at-home tests for vitamin D, Lyme disease, sexually transmitted infections, and thyroid function; researchers identified 42 genetic variants associated with dyslexia; FDA plans updated mammogram regulations to help women with dense breasts.
Read More
Combination of Tremelimumab and Durvalumab Approved by FDA for Unresectable Liver Cancer
October 24th 2022A dual immunotherapy option of tremelimumab, sold as Imjudo, in combination with durvalumab, sold as Imfinzi, was approved by the FDA Monday for the treatment of adult patients with unresectable hepatocellular carcinoma, the most common type of liver cancer.
Read More
The Biden administration will expand the use of medication to treat substance use disorders to include pregnant women; oversight of the nation’s poorest-performing nursing homes will be tightened; children’s hospitals are filling up with cases of respiratory syncytial virus and other respiratory diseases.
Read More
Endometriosis Has Quality-of-Life Impacts, Great Economic Burden, Dr Soyini Hawkins Says
October 21st 2022Endometriosis can have a long timeline from onset of symptoms to diagnosis, and in later stages it can affect organs other than the uterus, explained Soyini Hawkins, MD, gynecologist at Fibroid and Pelvic Wellness Center of Georgia.
Read More
The White House launched a national biodefense strategy to protect the country from future pandemics and biological threats; researchers found racial disparities in infant deaths following fertility treatments; global leaders pledged a total of $2.6 billion toward the Global Polio Eradication Initiative’s 2022-2026 Strategy.
Read More